Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Motivation for Alcohol in Alcohol Use Disorder
NCT06326684Phase 1Recruiting
- Start
- Jun 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of suvorexant in alcohol use disorder (AUD) (3 arms). Primary endpoint: Reinforcing Effects of Alcohol at 3 weeks. Started Jun 2024; status: recruiting.
02
Drugs
suvorexant
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06326684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06326684.